An Overview of Epigenetics in Obesity: The Role of Lifestyle and Therapeutic Interventions

被引:73
作者
Mahmoud, Abeer M. [1 ]
机构
[1] Univ Illinois, Dept Med, Coll Med, Div Endocrinol Diabet & Metab, Chicago, IL 60612 USA
关键词
obesity; epigenetics; energy metabolism; lifestyle; DNA methylation; histone modifications; microRNAs; diet; physical activity; weight loss; GENOMIC DNA METHYLATION; HIGH-FAT; SKELETAL-MUSCLE; GENE-EXPRESSION; ENDURANCE EXERCISE; ADIPOSE-TISSUE; MOUSE MODEL; HISTONE ACETYLATION; METABOLIC SYNDROME; WEIGHT-LOSS;
D O I
10.3390/ijms23031341
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity has become a global epidemic that has a negative impact on population health and the economy of nations. Genetic predispositions have been demonstrated to have a substantial role in the unbalanced energy metabolism seen in obesity. However, these genetic variations cannot entirely explain the massive growth in obesity over the last few decades. Accumulating evidence suggests that modern lifestyle characteristics such as the intake of energy-dense foods, adopting sedentary behavior, or exposure to environmental factors such as industrial endocrine disruptors all contribute to the rising obesity epidemic. Recent advances in the study of DNA and its alterations have considerably increased our understanding of the function of epigenetics in regulating energy metabolism and expenditure in obesity and metabolic diseases. These epigenetic modifications influence how DNA is transcribed without altering its sequence. They are dynamic, reflecting the interplay between the body and its surroundings. Notably, these epigenetic changes are reversible, making them appealing targets for therapeutic and corrective interventions. In this review, I discuss how these epigenetic modifications contribute to the disordered energy metabolism in obesity and to what degree lifestyle and weight reduction strategies and pharmacological drugs can restore energy balance by restoring normal epigenetic profiles.
引用
收藏
页数:21
相关论文
共 157 条
  • [1] The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus
    Ahmed, Sanabil Ali Hassan
    Ansari, Suraiya Anjum
    Mensah-Brown, Eric P. K.
    Emerald, Bright Starling
    [J]. CLINICAL EPIGENETICS, 2020, 12 (01)
  • [2] DNA Methylation Analysis in Nonalcoholic Fatty Liver Disease Suggests Distinct Disease-Specific and Remodeling Signatures after Bariatric Surgery
    Ahrens, Markus
    Ammerpohl, Ole
    von Schoenfels, Witigo
    Kolarova, Julia
    Bens, Susanne
    Itzel, Timo
    Teufel, Andreas
    Herrmann, Alexander
    Brosch, Mario
    Hinrichsen, Holger
    Erhart, Wiebke
    Egberts, Jan
    Sipos, Bence
    Schreiber, Stefan
    Haesler, Robert
    Stickel, Felix
    Becker, Thomas
    Krawczak, Michael
    Roecken, Christoph
    Siebert, Reiner
    Schafmayer, Clemens
    Hampe, Jochen
    [J]. CELL METABOLISM, 2013, 18 (02) : 296 - 302
  • [3] Al-Abri Mohammed A, 2016, Oman Med J, V31, P399, DOI 10.5001/omj.2016.81
  • [4] Adipose Tissue Hypoxia Correlates with Adipokine Hypomethylation and Vascular Dysfunction
    Ali, Mohamed M.
    Hassan, Chandra
    Masrur, Mario
    Bianco, Francesco M.
    Naquiallah, Dina
    Mirza, Imaduddin
    Frederick, Patrice
    Fernandes, Eduardo T.
    Giulianotti, Cristoforo P.
    Gangemi, Antonio
    Phillips, Shane A.
    Mahmoud, Abeer M.
    [J]. BIOMEDICINES, 2021, 9 (08)
  • [5] DNA methylation profile of genes involved in inflammation and autoimmunity correlates with vascular function in morbidly obese adults
    Ali, Mohamed M.
    Naquiallah, Dina
    Qureshi, Maryam
    Mirza, Mohammed Imaduddin
    Hassan, Chandra
    Masrur, Mario
    Bianco, Francesco M.
    Frederick, Patrice
    Cristoforo, Giulianotti P.
    Gangemi, Antonio
    Phillips, Shane A.
    Mahmoud, Abeer
    [J]. EPIGENETICS, 2022, 17 (01) : 93 - 109
  • [6] Alkandari Abdullah, 2018, BMC Obes, V5, P20, DOI 10.1186/s40608-018-0199-z
  • [7] Are epigenetic drugs for diabetes and obesity at our door step?
    Arguelles, Andrix O.
    Meruvu, Sunitha
    Bowman, John D.
    Choudhury, Mahua
    [J]. DRUG DISCOVERY TODAY, 2016, 21 (03) : 499 - 509
  • [8] Valproic Acid Is a Novel Activator of AMP-Activated Protein Kinase and Decreases Liver Mass, Hepatic Fat Accumulation, and Serum Glucose in Obese Mice
    Avery, Lindsay B.
    Bumpus, Namandje N.
    [J]. MOLECULAR PHARMACOLOGY, 2014, 85 (01) : 1 - 10
  • [9] HDAC11 suppresses the thermogenic program of adipose tissue via BRD2
    Bagchi, Rushita A.
    Ferguson, Bradley S.
    Stratton, Matthew S.
    Hu, Tianjing
    Cavasin, Maria A.
    Sun, Lei
    Lin, Ying-Hsi
    Liu, Dianxin
    Londono, Pilar
    Song, Kunhua
    Pino, Maria F.
    Sparks, Lauren M.
    Smith, Steven R.
    Scherer, Philipp E.
    Collins, Sheila
    Seto, Edward
    McKinsey, Timothy A.
    [J]. JCI INSIGHT, 2018, 3 (15):
  • [10] Chemical toxins: A hypothesis to explain the global obesity epidemic
    Baillie-Hamilton, PF
    [J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2002, 8 (02) : 185 - 192